Eurofins Scientific SE
ERF
Rank in Stocks
#1332
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Share Price
$96.58
Market Cap
$16.77B
Change (1 day)
3.06%
Change (1 year)
33.21%
Country
LU
Trade Eurofins Scientific SE (ERF)
Category
Healthcare
Revenue for Eurofins Scientific SE (ERF)
Revenue in Jun 2026 TTM: $8.76B
According to Eurofins Scientific SE latest financial reports the company's current revenue (TTM) is $8.76B. In 2024 the company made a revenue of $7.23B an increase over the revenue in the year 2023 that was $7.20B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eurofins Scientific SE from 2002 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $8.76B | 2.33% |
| 2025 | $8.56B | 18.35% |
| 2024 | $7.23B | 0.43% |
| 2023 | $7.20B | 0.02% |
| 2022 | $7.20B | -5.75% |
| 2021 | $7.64B | 15.33% |
| 2020 | $6.62B | 29.39% |
| 2019 | $5.12B | 17.82% |
| 2018 | $4.35B | 21.87% |
| 2017 | $3.57B | 33.59% |
| 2016 | $2.67B | 26.05% |
| 2015 | $2.12B | 24.10% |
| 2014 | $1.71B | 1.24% |
| 2013 | $1.69B | 22.39% |
| 2012 | $1.38B | 28.33% |
| 2011 | $1.07B | 17.97% |
| 2010 | $909.59M | -0.89% |
| 2009 | $917.78M | 4.08% |
| 2008 | $881.83M | 22.68% |
| 2007 | $718.83M | 48.46% |
| 2006 | $484.20M | 75.80% |
| 2005 | $275.43M | 15.73% |
| 2004 | $238.00M | 12.05% |
| 2003 | $212.41M | 25.25% |
| 2002 | $169.59M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 428.96% |
US
|
|
| $25.11B | 186.62% |
US
|
|
| $2.71B | -69.10% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -15.84% |
US
|
